Matthew Ronsheim - Net Worth and Insider Trading
Matthew Ronsheim Net Worth
The estimated net worth of Matthew Ronsheim is at least $101,268 dollars as of 2024-05-30. Matthew Ronsheim is the See Remarks of Entasis Therapeutics Holdings Inc and owns about 46,241 shares of Entasis Therapeutics Holdings Inc (ETTX) stock worth over $101,268. Details can be seen in Matthew Ronsheim's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew Ronsheim has not made any transactions after 2021-10-19 and currently still holds the listed stock(s).
Transaction Summary of Matthew Ronsheim
Matthew Ronsheim Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Ronsheim owns 1 companies in total, including Entasis Therapeutics Holdings Inc (ETTX) .
Click here to see the complete history of Matthew Ronsheim’s form 4 insider trades.
Insider Ownership Summary of Matthew Ronsheim
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc | 2021-10-19 | See Remarks |
Matthew Ronsheim Latest Holdings Summary
Matthew Ronsheim currently owns a total of 1 stock. Matthew Ronsheim owns 46,241 shares of Entasis Therapeutics Holdings Inc (ETTX) as of October 19, 2021, with a value of $101,268.
Latest Holdings of Matthew Ronsheim
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc | 2021-10-19 | 46,241 | 2.19 | 101,268 |
Holding Weightings of Matthew Ronsheim
Matthew Ronsheim Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Ronsheim has made a total of 1 transactions in Entasis Therapeutics Holdings Inc (ETTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Entasis Therapeutics Holdings Inc is the sale of 3,759 shares on October 19, 2021, which brought Matthew Ronsheim around $11,991.
Insider Trading History of Matthew Ronsheim
- 1
Matthew Ronsheim Trading Performance
Matthew Ronsheim Ownership Network
Matthew Ronsheim Owned Company Details
What does Entasis Therapeutics Holdings Inc do?
Who are the key executives at Entasis Therapeutics Holdings Inc?
Matthew Ronsheim is the See Remarks of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and Chief Medical Officer David Altarac .
Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entasis Therapeutics Holdings Inc Insider Transactions
Matthew Ronsheim Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Ronsheim. You might contact Matthew Ronsheim via mailing address: 35 Gatehouse Drive Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
